pre-2010

2009


May M, CD4+ T Cell Count Decreases by Ethnicity among Untreated Patients with HIV Infection in South Africa and Switzerland J Infect Dis. 2009 Dec 1;200(11):1729-35.
Download: Abstract

Losina E,Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal.PLoS Med. 2009 Oct;5(10) :e1000173. Epub 2009 Oct 27. Abstract

Davies MA,  Outcomes of the South African National Antiretroviral Treatment (ART) programme for children -  the IeDEA Southern Africa Collaboration.S Afr Med J. 2009 Oct;99(10):730-737.Abstract

Davies MA, Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies.African Journal of AIDS Research 2009, 8(3): 329-338 Download: Abstract

Keiser O, Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy.Trop Med & Int Hlth, 2009 Oct; 14(10) : 1220-5 Abstract

ART-LINC, Switching to second-line therapy antiretroviral therapy in resource-limited settings: Comparison of programmes with and without access to viral load monitoring. AIDS. 2009 Sep 10;23(14):1867-74.Download: Abstract

Cornell M, Monitoring the South African Antiretroviral programme 2003-2007: The IeDEA Southern Africa Collaboration.S Afr Med J 2009; 99: 653-660. Abstract.

Cornell M, The impact of gender and income on survival and retention in a South African antiretroviral therapy programme.Trop Med Int Health. 2009 Jul;14(7):722-31.Download: Abstract

Brinkhof MW, Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis.PLoS ONE 4(6): e5790. doi:10.1371/ journal.pone. 0005790.Abstract.

Brinkhof MW, Mortality of HIV-Infected Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Comparison with HIV-Unrelated Mortality.PLoS Med. 2009 Apr 28;6(4):e1000066.Abstract

2008


Forster M, Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings.Bull World Health Organ. 2008, 86 (12): 939-947.Abstract

Nash D, Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.AIDS. 2008 Nov 12;22(17):2291-302.Abstract

Brinkhof MW, Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.Bull World Health Organ. 2008 Jul;86(7):559-67.Abstract

Keiser O, Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.Trop Med Int Health. 2008 Jul;13(7):870-9.Abstract

Keiser O, Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared.PLoS Med. 2008 Jul 8;5(7):e148. Abstract

Brinkhof MW, Egger M, Reply to Colebunders and Caluwaerts.CID, 2008:46 (1May): 1482.

Colebunders R, Caluwaerts S, Determination of the Incidence of Tuberculosis in Low-Income Countries.
CID, 2008:46 (1May): 1482.

Braitstein P, Gender and the Use of Antiretroviral Treatment in Resource-Constrained Settings: Findings from a Multicenter Collaboration. J Womens Health (Larchmt). 2008 Jan-Feb;17(1):47-55. Abstract

2007

__________________________________________________________________________________

Brinkhof MW,Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.Clin Infect Dis. 2007 Dec 1;45(11):1518-21. Abstract

Tuboi S, Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.J Acquir Immune Defic Syndr. 2007 May 1;45(1):52-9. Abstract

Boulle A, Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.Antivir Ther. 2007;12(5):753-60. Abstract  

2006


Brinkhof MW, Mortality of HIV-infected patients in low-income countries (letter).Lancet 2006; 368: 2207-8.

Braitstein P, Brinkhof MW, Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.Lancet 2006;367:817-24. Abstract


Dabis F, Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts. Int J Epidemiol. 2005 Oct;34(5):979-86. Abstract

©  ISPM - University of Bern 2015